all names

Global Product Development organisation

Named in 2 reports across 1 story - 2 Oct – 21 Oct
2 Oct 202621 Oct 2026

Closest companions, sized by how often they share a report with Global Product Development. Lines between the outer names are their own relationships - names that appear together even without Global Product Development.

California and Genentech share 1 reportCalifornia and Fenebrutinib Fentrepid share 1 reportLevi Garraway and Michelle Mccourt share 1 reportFenebrutinib Fenhance and Levi Garraway share 1 reportLevi Garraway and Loren Kalm share 1 reportGenentech and Lily Rose Atherton share 1 reportDrug Administration and Levi Garraway share 1 reportBruno Eschli and California share 1 reportBruno Eschli and Fenebrutinib Fenhance share 1 reportBruno Eschli and Genentech share 1 reportBruno Eschli and Levi Garraway share 1 reportLevi Garraway and Lily Rose Atherton share 1 reportFenebrutinib Fentrepid and Lily Rose Atherton share 1 reportFenebrutinib Fenhance and Lily Rose Atherton share 1 reportCalifornia and Fenebrutinib Fenhance share 1 reportFenebrutinib Fenhance and Genentech share 1 reportBruno Eschli and Lily Rose Atherton share 1 reportBruno Eschli and Michelle Mccourt share 1 reportFenebrutinib Fentrepid and Michelle Mccourt share 1 reportFenebrutinib Fentrepid and Loren Kalm share 1 reportCalifornia and Levi Garraway share 1 reportBruno Eschli and Loren Kalm share 1 reportCalifornia and Loren Kalm share 1 reportGenentech and Loren Kalm share 1 reportGenentech and Michelle Mccourt share 1 reportGenentech and Levi Garraway share 1 reportLoren Kalm and Michelle Mccourt share 1 reportFenebrutinib Fentrepid and Levi Garraway share 1 reportFenebrutinib Fenhance and Fenebrutinib Fentrepid share 1 reportLily Rose Atherton and Michelle Mccourt share 1 reportBruno Eschli and Fenebrutinib Fentrepid share 1 reportCalifornia and Michelle Mccourt share 1 reportCalifornia and Lily Rose Atherton share 1 reportFenebrutinib Fenhance and Loren Kalm share 1 reportLily Rose Atherton and Loren Kalm share 1 reportFenebrutinib Fentrepid and Genentech share 1 reportFenebrutinib Fenhance and Michelle Mccourt share 1 reportGlobal Product Developm…Levi GarrawayLevi Garraway - 2 shared reports (person)Bruno EschliBruno Eschli - 1 shared report (person)CaliforniaCalifornia - 1 shared report (place)Drug Admini…Drug Administration - 1 shared report (organization)Fenebrutini…Fenebrutinib Fenhance - 1 shared report (person)Fenebrutinib Fent…Fenebrutinib Fentrepid - 1 shared report (person)GenentechGenentech - 1 shared report (organization)Lily Rose A…Lily Rose Atherton - 1 shared report (person)Loren KalmLoren Kalm - 1 shared report (person)Michelle Mc…Michelle Mccourt - 1 shared report (person)

The stories

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026

74 outlets2 reports name Global Product Development5 Aug – 6 Nov

Who keeps naming them

neurologyadvisor.com1thesudburystar.com1

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.